In experiments with mice, researchers have studied neuronal mechanisms and found a way to, by and large, prevent spasticity from developing after spinal cord injuries.…
Quality improvement effort cuts blood clots in brain injury patients
(HealthDay)—Implementation of an anticoagulation protocol reduces blood clots in patients with traumatic brain injury (TBI), according to a study published in the April 1 issue…
Why are so many people dying of COVID-19 in New York City?
New York is being hit the hardest by the novel coronavirus spreading across the U.S., with more cases and more related deaths per capita than…
Racial disparity in prostate cancer survival tied to region
(HealthDay)—National, race-based differences in prostate cancer survival are due to regional variation, even for low-risk prostate cancer, according to a study published online March 31…
Love in the time of coronavirus: 5 tips for communicating with your partner while stuck at home
Many of us are several weeks into stay-at-home directives from our governments and health officials. For many, social distancing means sharing a confined space with…
Ticks-time starts: That should be observed in nature, Naturopathy, naturopathic specialist portal
Ticks are more active In the Corona-crisis, where the social meeting places are closed, company-a lot of people long walks in the nature. The beautiful…
Breathing techniques to calm yourself down if you're panicking in self-isolation
If you’re starting to go stir-crazy in self-isolation, don’t worry – you’re not the only one and it’s a completely normal feeling. But just because it’s…
Sanofi offers 100 mln doses of hydroxychloroquine in COVID-19 fight
French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if…
Newly emerged enterovirus-A71 C4 isolates may be more virulent than B5 in northern Vietnam
Hand-foot-and-mouth disease (HFMD) is an acute viral infection that usually affects infants and children of less than five years. In a study published in Scientific…
World-first trial to test benefit of intravenous zinc in COVID-19 fight
A world-first trial will see researchers from Austin Health and the University of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The…